BLFS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
28.5M
+3.5%
27.5M
+46.4%
18.8M
-33.1%
28.1M
+19.7%
23.4M
Cost of Revenue
10.2M
+1.7%
10.0M
+46.9%
6.8M
-32.9%
10.1M
+23.7%
8.2M
Gross Profit
18.3M
+4.5%
17.5M
+46.1%
12.0M
-33.2%
17.9M
+17.6%
15.2M
Operating Expenses
16.6M
-5.0%
17.5M
+64.3%
10.6M
-41.0%
18.0M
-42.6%
31.4M
R&D
3.0M
+11.6%
2.6M
-82.9%
15.5M
+470.5%
2.7M
-84.5%
17.5M
SG&A
13.5M
-8.5%
14.7M
+17.5%
12.5M
-14.1%
14.6M
+5.7%
13.8M
Operating Income
1.7M
+6181.5%
27.0K
-98.0%
1.3M
+1613.5%
-89000
+99.4%
-16126000
EBITDA
2.5M
+245.0%
726.0K
-62.4%
1.9M
+55.1%
1.2M
+108.5%
-14744000
Net Income
45.1M
+3703.0%
1.2M
-89.3%
11.1M
+1682.6%
621.0K
+103.9%
-15838000
EPS (Basic)
$0.92
+4500.0%
$0.02
-91.3%
$0.23
+2200.0%
$0.01
+103.0%
$-0.33
EPS (Diluted)
$0.91
+4450.0%
$0.02
-90.9%
$0.22
+2100.0%
$0.01
+103.0%
$-0.33
Shares (Diluted)
49.3M
+0.1%
49.2M
-0.9%
49.7M
+2.0%
48.7M
+1.9%
47.8M
BioLife Solutions (BLFS) โ€” Financials